Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Royal DSM NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Royal DSM NV, Medical Devices Deals, 2012 to YTD 2018 10
Royal DSM NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Royal DSM NV, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Verdezyne Raises US$48 Million In Venture Financing 13
Arecor Raises Funds Through Venture Financing 15
Private Equity 16
Bain Capital Private Equity Acquires DSM Sinochem Pharma from Royal DSM and Sinochem Group 16
Partnerships 18
Aerie Pharma Enters into R&D Agreement with Royal DSM 18
OptiBiotix Health Enters into Co-Development Agreement with Royal DSM 19
Royal DSM Forms Joint Venture With JLL Partners 20
Licensing Agreements 22
Aerie Pharma Expands Licensing Agreement with DSM Biomedical 22
Equity Offering 23
Amyris Raises USD50 Million in Second and Final Tranche of Private Placement of Shares 23
Amyris Raises USD47 Million in First Tranche of Private Placement of Shares 25
ChromaDex Completes Private Placement Of Shares For US$3 Million 27
Debt Offering 28
Royal DSM Completes Public Offering Of Bonds Due 2024 For US$684 Million 28
Royal DSM Announces Public Offering Of Notes Due 2019 For US$412.84 Million 29
Royal DSM Completes Private Placement Of Bonds Due 2019 For US$405 Million 30
Acquisition 31
Royal DSM Acquires Amyris Brasil 31
Royal DSM Acquires Biocare Copenhagen 32
i-Health to Acquire UP4 Probiotics from UAS Labs 33
Royal DSM Acquires Aland Nutraceutical 34
DSM Completes Acquisition Of Fortitech, Nutraceutical Company, For US$634 Million 35
Royal DSM Completes Acquisition Of Ocean Nutrition Canada For US$532.7 Million 37
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 39
Royal DSM NV – Key Competitors 41
Royal DSM NV – Key Employees 42
Royal DSM NV – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Joint Venture 46
Recent Developments 48
Strategy And Business Planning 48
Apr 03, 2017: Royal DSM Opens New Biotechnology Center in Delft, the Netherlands 48
Financial Announcements 49
Aug 01, 2018: DSM announces H1 2018 results 49
May 08, 2018: DSM Reports Q1 2018 Results 50
Feb 15, 2018: DSM Reports 2017 Results 51
Nov 02, 2017: DSM Reports Results First Nine Months 2017 58
May 02, 2017: DSM Q1 2017 Results 59
Feb 15, 2017: DSM reports 2016 results 60
Feb 14, 2017: DSM new presentation of accounts as from Q4 2016 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Royal DSM NV, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Royal DSM NV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Royal DSM NV, Deals By Therapy Area, 2012 to YTD 2018 9
Royal DSM NV, Medical Devices Deals, 2012 to YTD 2018 10
Royal DSM NV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Verdezyne Raises US$48 Million In Venture Financing 13
Arecor Raises Funds Through Venture Financing 15
Bain Capital Private Equity Acquires DSM Sinochem Pharma from Royal DSM and Sinochem Group 16
Aerie Pharma Enters into R&D Agreement with Royal DSM 18
OptiBiotix Health Enters into Co-Development Agreement with Royal DSM 19
Royal DSM Forms Joint Venture With JLL Partners 20
Aerie Pharma Expands Licensing Agreement with DSM Biomedical 22
Amyris Raises USD50 Million in Second and Final Tranche of Private Placement of Shares 23
Amyris Raises USD47 Million in First Tranche of Private Placement of Shares 25
ChromaDex Completes Private Placement Of Shares For US$3 Million 27
Royal DSM Completes Public Offering Of Bonds Due 2024 For US$684 Million 28
Royal DSM Announces Public Offering Of Notes Due 2019 For US$412.84 Million 29
Royal DSM Completes Private Placement Of Bonds Due 2019 For US$405 Million 30
Royal DSM Acquires Amyris Brasil 31
Royal DSM Acquires Biocare Copenhagen 32
i-Health to Acquire UP4 Probiotics from UAS Labs 33
Royal DSM Acquires Aland Nutraceutical 34
DSM Completes Acquisition Of Fortitech, Nutraceutical Company, For US$634 Million 35
Royal DSM Completes Acquisition Of Ocean Nutrition Canada For US$532.7 Million 37
DSM Completes Acquisition Of Kensey Nash, Regenerative Medicine Company, For US$360 Million 39
Royal DSM NV, Key Competitors 41
Royal DSM NV, Key Employees 42
Royal DSM NV, Other Locations 43
Royal DSM NV, Subsidiaries 43
Royal DSM NV, Joint Venture 46
List of Figures
Royal DSM NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Royal DSM NV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Royal DSM NV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Royal DSM NV, Medical Devices Deals, 2012 to YTD 2018 10